Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, 3-Arm, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Impact of Diamyd on the Progression of Diabetes in Patients Newly Diagnosed With Type 1 Diabetes Mellitus (USA)

NCT00751842 is registered in ClinicalTrials.gov with Diamyd Therapeutics AB as lead sponsor.

NCT NCT00751842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00751842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, 3-Arm, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Impact of Diamyd on the Progression of Diabetes in Patients Newly Diagnosed With Type 1 Diabetes Mellitus (USA)
Lead sponsor
Diamyd Therapeutics AB
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2008
Completion date
July 31, 2012
Enrollment
331 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus